04 April 2026
Pure Global: Brazil's UDI Deadline Chaos - A MedTech Compliance Crisis.
LATAM MedTech Insights
About
This episode of LATAM MedTech Insights dives into the immediate fallout from ANVISA's sudden enforcement of its Unique Device Identification (UDI) system in Brazil. We unpack the operational chaos this is causing for MedTech manufacturers who were unprepared for the complex data submission and labeling requirements.
We explore how this regulatory shift is more than a bureaucratic hurdle. it represents a fundamental change in what it takes to access and succeed in Latin America's largest market. We discuss the critical role of the Brazil Registration Holder (BRH) and how a simple data mismatch can derail an entire product launch.
A specific case we're seeing is a European scale-up whose fully approved diagnostic device is now blocked from the Brazilian market. Their multi-million dollar launch is on hold, not due to product quality, but because of a failure to meet the new UDI data submission protocols before their shipment arrived, a critical detail that has jeopardized their entire market entry strategy.
Key Takeaways This Episode:
1. Why is ANVISA's new UDI enforcement causing a crisis for even experienced MedTech companies?
2. What are the most common mistakes manufacturers make when submitting UDI data to the Brazilian database?
3. How can your choice of a Brazil Registration Holder make or break your market access right now?
4. Is this UDI requirement just a Brazilian issue, or is it the blueprint for the rest of Latin America?
5. What are the hidden costs of UDI non-compliance that go far beyond regulatory fines?
6. How does this new rule impact your existing supply chain and logistics in Brazil?
7. Are your global technical dossiers truly prepared for these new local data integration demands?
Navigating complex regulatory landscapes is our expertise. Pure Global offers end-to-end solutions for MedTech companies, combining local, in-country experts with advanced AI tools to streamline global market access. From regulatory strategy and technical dossier submission to serving as your local representative in Brazil, we ensure you are always ahead of the curve. Don't let regulatory surprises disrupt your growth. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to learn more.
We explore how this regulatory shift is more than a bureaucratic hurdle. it represents a fundamental change in what it takes to access and succeed in Latin America's largest market. We discuss the critical role of the Brazil Registration Holder (BRH) and how a simple data mismatch can derail an entire product launch.
A specific case we're seeing is a European scale-up whose fully approved diagnostic device is now blocked from the Brazilian market. Their multi-million dollar launch is on hold, not due to product quality, but because of a failure to meet the new UDI data submission protocols before their shipment arrived, a critical detail that has jeopardized their entire market entry strategy.
Key Takeaways This Episode:
1. Why is ANVISA's new UDI enforcement causing a crisis for even experienced MedTech companies?
2. What are the most common mistakes manufacturers make when submitting UDI data to the Brazilian database?
3. How can your choice of a Brazil Registration Holder make or break your market access right now?
4. Is this UDI requirement just a Brazilian issue, or is it the blueprint for the rest of Latin America?
5. What are the hidden costs of UDI non-compliance that go far beyond regulatory fines?
6. How does this new rule impact your existing supply chain and logistics in Brazil?
7. Are your global technical dossiers truly prepared for these new local data integration demands?
Navigating complex regulatory landscapes is our expertise. Pure Global offers end-to-end solutions for MedTech companies, combining local, in-country experts with advanced AI tools to streamline global market access. From regulatory strategy and technical dossier submission to serving as your local representative in Brazil, we ensure you are always ahead of the curve. Don't let regulatory surprises disrupt your growth. Contact us at info@pureglobal.com or visit https://pureglobal.com/ to learn more.